Cat. No.: X23-10-ZQ361
JAK inhibitor BMS-066, Purity ≥98%
Synonym: BMS-066; 914946-88-6; BL7XSD8R7B; N-((6-(1,6-Dihydro-1-methyl-4-(methylamino)imidazo(4,5-d)pyrrolo(2,3-b)pyridin-7-yl)-2-pyridinyl)methyl)-2-methoxyacetamide; JAK inhibitor
- CAS Number: 914946-88-6
- Compound CID: 24825710
Product Size
1 mg; 5 mg; 10 mg; 25 mg
Properties
Description
BMS-066 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets IKKβ and TYK2.
Molecular Formula
C19H21N7O2
Targets
IKKβ: 9 nM; TYK2: 72 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS-066 can be used to study its potential as a JAK2 inhibitor in various cancers and immune disorders.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links